Efstratios A. Apostolou

Cardiologist | Heart Failure, Health Policy, HTA | Affiliated with @uoaofficial and @LSE_MTRG

[Efstratios A. Apostolou @EApostolouMD]

Glad we move towards simplification and harmonization. These are the keys to successful #implementation, which remains the biggest challenge.

[Eiran Gorodeski, MD, MPH @EiranGorodeski]

The Europeans have reframed how we should think about heart failure categorization… and it makes sense to me.

[Efstratios A. Apostolou @EApostolouMD]

@arthur_alb1 @mvaduganathan @gcfmd @SJGreene_md @JavedButler1 @ValleAlfonso @ankeetbhatt @dranulala @ShelleyZieroth @DrMarthaGulati @AndrewJSauer @Kieranfdocherty RALES and EMPHASIS-HF provided the evidence for EF up to 35%. FINEARTS-HF the strongest evidence for EF 40% or higher. The patient-level meta-analysis of the 4 landmark trials (incl. TOPCAT) built the totality of evidence which shaped the new guidelines. https://t.co/Ed5I93Mldi

[Efstratios A. Apostolou @EApostolouMD]

@YPsar Το συστημα δεν ευνοει την αναπτυξη γηγενων παικτων. Ολοκληρο Γιαννη, οι εγχωριοι δεν τον εβλεπαν καν. Ποια αυτιά και ποια μετρα να λαβουν; Διαχειριση ρηχης δεξαμενης κανουν και ελληνοποιησεις.

[European Society of Cardiology Journals @ESC_Journals]

Evaluation and management of HF patients with liver disease
💡 Understanding this heart–liver interaction is 🗝️ to better patient care.
👉 https://t.co/Lz7RmZEgAl

@EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd
#EJHF

[Efstratios A. Apostolou @EApostolouMD]

@FotisKokotos Πρώτη φορά με γυάλινο καλαμάκι και πολύ το απόλαυσα. Δυστυχώς όχι στην Ελλάδα.

[HF Collaboratory @hfcollaboratory]

Out now in @CircHF from #HFC members @FudimMarat @JavedButler1 et al.

This review examines cardiac microcurrent therapy (C-MIC) as an emerging approach for HFrEF, its potential effects on cardiac repair and remodeling, and the need for larger studies. https://t.co/slT6COCYxP

[UEFA Champions League @ChampionsLeague]

AEK Athens are through to the league phase 💪

#UCL

[Eric Topol @EricTopol]

The path to preventing Type 2 diabetes and prediabetes across the lifespan, and when glucose intolerance crops up, to achieve remission
https://t.co/HGcGoNM2O4
@Dr_Birkenfeld @NatureMedicine @uktuebingen

[EJHF Editor-in-Chief @EJHFEiC]

Revascularization of coronary artery disease in heart failure: a European Journal of Heart Failure expert consensus statement

#EJHF @ESC_Journals

https://t.co/96pNN23JoV
@HanCardiomd @AmrAbdin10 @GiuseppeGalati_

[Ahmed Bennis MD 🫀 @drbennisahmed]

Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure international expert position paper

The purpose of the current review is to highlight the growing epidemiology of concurrent HF-liver disease

https://t.co/WzbdHRqrgA

[HF Collaboratory @hfcollaboratory]

Now in @JACCJournals Liver for the Cardiologist by @FudimMarat

This article highlights why MASLD should be integrated into CKM care, its relevance to heart failure, and the role of FIB-4 assessment in routine cardiology practice. https://t.co/KEhbZxYJd1

[Efstratios A. Apostolou @EApostolouMD]

Chronic liver disease is an understudied, inadequately assessed and managed comorbidity in #HF.

We just published a comprehensive approach to the complex heart-liver interplay, how to assess severity and address common scenarios. #EJHF

High #unmetneed in RCT development.

[EJHF Editor-in-Chief @EJHFEiC]

Evaluation and management of HF patients with liver disease: #EJHF international expert position paper

https://t.co/g0Ws72tQgs

@SolovevaAnzhela @ARakisheva @HanCardiomd @AmrAbdin10 @GiuseppeGalati_

[Ankeet S. Bhatt, MD, MBA, ScM @ankeetbhatt]

New from the @ACCinTouch:2026 ACC Clinical Guidance on Adult Immunizations as Part of CV Care. Honored to serve as Vice Chair of this effort. Evidence growing that vaccines influence CV risk reduction not just infection prevention. In press @JACCJournals https://t.co/5emXtjAuie

[JACC Journals @JACCJournals]

As cardiovascular-kidney-metabolic (CKM) care becomes routine, someone has to own the coordination. A new #JACC commentary makes the case: cardiologists. https://t.co/HF4KmN3Tqb

#CKMSyndrome #CKM @mvaduganathan @brendonneuen

[EJHF Editor-in-Chief @EJHFEiC]

Evaluation and management of HF patients with liver disease: #EJHF international expert position paper

https://t.co/g0Ws72tQgs

@SolovevaAnzhela @ARakisheva @HanCardiomd @AmrAbdin10 @GiuseppeGalati_

[Anzhela Soloveva @SolovevaAnzhela]

Our HF-liver position paper is out!
@EJHFEiC

https://t.co/6W3qIgP28q

Grateful for the opportunity to collaborate with such an outstanding team and for the constant support - thanks a lot! especially to dear @ARakisheva❤️ it wouldn’t have been possible w/o your encouragement

[Marat Fudim, MD MHS @FudimMarat]

The CKM framework has changed how we think about cardiometabolic disease. One organ still sits too far from center stage: the liver

This new paper argues that MASLD should be treated as a core part of CKM biology, not simply another associated condition
https://t.co/q8Ne38nFw8

[Ahmed Bennis MD 🫀 @drbennisahmed]

This is a treatment algorithm for optimal therapy in HFpEF

Under SGLT2i:

Fluid retention → titrate diuretic agent

BMI ≥30 → add incretin-based therapy (e.g., GLP-1 agonists)

Women (any EF), men with LVEF <55–60%, or hypertension → add ARNI

https://t.co/LtDakOyxO1

[Efstratios A. Apostolou @EApostolouMD]

@KerryTsolakis Ο κεντρικός δρόμος στον Κρούστα Λασιθίου με τις υπέροχες μουριές του.

[Julia Grapsa @JGrapsa]

Assessing LV diastolic function is one of the most nuanced tasks in echocardiography, overlapping terminology, load dependence, and discordant parameters make it genuinely hard to do consistently at the bedside.

This review in #EHJCVI offers a pragmatic, tier-based framework built around the 2025 ASE recommendations, using a probabilistic approach that integrates clinical context, echo findings, advanced imaging, and emerging AI to sharpen both diagnosis and prognosis.

Kudos to Dr @argulian , who led this work with exceptional clarity and vision. Beyond being one of the very best imaging cardiologists in the world, Edgar is a wonderful clinician and exceptional human being. It is a privilege to learn from and collaborate with him.

And what an honour to share authorship with two giants of the field, @SNagueh and @OttoSmiseth , whose work has shaped how all of us think about diastology.

Don’t miss it ➡️ https://t.co/Gt32R2DzqA

#Echocardiography #Cardiology #DiastolicFunction #HeartFailure #CardiacImaging #EHJCVI